Home › Islet Cell Adenoma › Oregon › Portland
Islet Cell Adenoma clinical trials in Portland, OR
4 studies for Islet Cell Adenoma are looking for participants at sites in and around Portland (within about 30 miles). Open a study to see who can join and how to contact the study team.
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
RecruitingPhase 2/3
- Oregon Health and Science University, Portland
A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
RecruitingPhase 3
- Investigative Site, Portland
Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.
RecruitingPhase 1
- Research Facility, Portland
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
RecruitingPhase 2
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Oregon Health and Science University, Portland
- and 1 more
Islet Cell Adenoma trials in other cities
- Los Angeles, CA5 studies
- Rochester, MN5 studies
- St. Louis, MO5 studies
- Chicago, IL4 studies
- Washington, DC4 studies
- Columbus, OH4 studies
- Lexington, KY4 studies
- Phoenix, AZ4 studies
- Salt Lake City, UT4 studies
- Nashville, TN3 studies
- Cedar Rapids, IA3 studies
- Boston, MA3 studies
Other studies in Portland
- Non-Small Cell Lung Cancer45 studies
- Cancer (all types)35 studies
- Prostate Cancer33 studies
- Breast Cancer32 studies
- Metastatic Cancer30 studies
- Colorectal Cancer28 studies
- Ovarian Cancer27 studies
- Lung Cancer26 studies
- Endometrial Cancer25 studies
- Acute Myeloid Leukemia25 studies
- Head and Neck Squamous Cell Carcinoma19 studies
- Pancreatic Cancer19 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.